ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
132 hedge funds and large institutions have $755M invested in Achillion Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 32 increasing their positions, 43 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
132
Holders Change
+10
Holders Change %
+8.2%
% of All Funds
2.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
42
Increased
32
Reduced
43
Closed
31
Calls
$30M
Puts
$78.5M
Net Calls
-$48.4M
Net Calls Change
-$49.5M
Top Buyers
| 1 |
VI
Versor Investments
New York
|
+$45.3M |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$45.3M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$33.1M |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$19.1M |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
+$17.2M |
Top Sellers
| 1 |
RI
RTW Investments
New York
|
-$39.5M |
| 2 |
Goldman Sachs
New York
|
-$18.9M |
| 3 |
Millennium Management
New York
|
-$16.5M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$12.5M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$11.1M |
